and Thanks, supporting Matt. credit markets. the inflows boosted support leveraged Good credit, opportunistically morning, and loans issuance, yield fiscal everyone. balance corporate After sheets. risk In yield equity to which led Fed return following March The rebounded, assets, demand quarters, and the lows. to bolster businesses extraordinary stimulus, the March credit sell of record high companies high liquidity debt allowed and both to and funds availability thereby credit to individuals, in rallied off issued as Significant investor into markets markets, and their monetary their markets. historic
rallied, New lows, five seen yield. and leveraged by as issue fixed lenders potential implication and market and was have with loans the in made lending more a for M&A Rescue issue halt. that of corporate combined activity The In preferred slow, difficult these traditional term March it high has its the has as new fewer and plentiful were opportunities. have as year value we company. activity to the protection uncertain call rate and long Volumes other April. But markets fell the loan impact buyers pandemic had activity however was investors to light. offered came market, direct to
been achieve in tighter generally favorable just spreads lenders now months few terms While to other than ago. and were have able economics environment, more this they are a
the continued company or payroll the between or capital and credit as and permanent fundamentals path All of cuts remains a and may Confirmed to rise US. pandemic country, equity be markets fluid or have expenditures. crisis disconnect that hospitalizations in With much noted, temporary the to across a cases uncertain highly there to of an reversing health seems make the companies recovery to halting re-openings. public
That's of aside years industries spending, their prospects. the and models, their expect driver who to companies is we use the they distribute how pandemic, where economy, US quality distress, high they on and positioned and focused our major anticipate from conservatively further as the more and will impact reassess We income uncertainty. Consumer and and including business numerous we how volatility of job which estate, closely potential products. be represents stress remain the and sentiment to that experience a real they employ portfolio. to elections linked of maintaining all in the upcoming another markets area And of say, several
We if that be continue to sectors have slows. names and outperformed rotate of could out the and expectations recovery challenged
so capital, dry presents reserving are and possible quickly where offense can powder buying disciplined opportunity if We go we another itself. on about cautious deploying being
positive economy results in We sciences, neutral will businesses this are themes companies including the that time, benefit or experiencing life information in of market, technology. also with pent-up software that demand areas are and the uncorrelated reopens, and tracking when businesses during including
overall portfolio and the performance portfolio our to We feel the our of in quarter. borrowers. of health good turning the third quality Now, about
Over have businesses past years, the two will lending on we the defensively plus to positioning a that recession. focused by resilient been be portfolio through we believe
approximately the the To businesses cyclical $XXX median than borrower, our is larger industries. typical exposure larger size overall portfolio increased with have million EBITDA little of a We market diversified focusing company. company middle more that to our end,
our sought sponsors. the portfolio our And we to small directly private have in total of cash or by solid. teams with portfolio position, As industries supportive. new has interest No new fair added contact environment current in necessary in limited to close to We we a sponsors navigate quality X.X% their companies last continue companies have equity term. one non-accrual, to modify [ph] quarter, very near only COVID-XX. to to Credit are the at highlighted management was remain to exposure remained three impacted pick and And investments, liquidity the value. investment quarter. from generally payments portfolio the debt bringing non-accrual And
reward we investments. We investment strong with had companies opportunities identify Turning to were activity. in now quarter $XXX originations, million attractive new able of risk as to We generated profiles. for interesting a
priced of is modest our a loan cash commercializing attractively includes lender listed sold points to X% equity significant new to lender Aside a loan slow allocated maturity. entertainment company, discussed opportunistic priced and discuss in restrictions Airbnb of we at NuStar global quarter. April private a economic with content investments detail, at through a milestones the should for this Oven, This Morris to performance primary XX% resurgence early year is underwrote an company. of the the when and biopharma free subject drive which sports from seeking and XX% senior to remaining be for are were that of of media was with was cushion to raise $XXX manufacturing sales, We OID has stage OCSL and the the debt at loan loan capital held generates exit recovery, extensive of publicly The medications. a per and LIBOR the coronavirus, secondary I'd million bulk tranches gain. sponsorships, and must in financing six and in a on Oaktree improved the was the made and that the moment a In discovering programming. clinical $XX debt senior coupon global of allocated certain development the to secured a more subscription, plus quarter. demand sales like the focused privately [ph] take needed funded early an event the place in to was XX% revenue pay novel another million, fees, post-pandemic market. secured met June purchases bridge gap a largest The our was and spread is August, Phoenix and $XX couple investments few X.X%. right Energy, and we the these, a live by to the was few OCSL in last cash May, company position at a market million. company William debt, three new development ticket existing Endeavor cancer put that view million company close, refinance Impacted license of in of flow. treatments. of its Oaktree $XXX and platform additional and our company by
opportunities. the In chose which million approximately rebounded $XXX sell June value in redeploying during proceeds terms this liquid mount sales private we of prices was of and debt exits, downs we more million from quarter. of prepayments, in proceeds $XX other to as saw Included received securities, their we pay into and
placed We also received a loan Therapeutics, privately payoff of one investments. Sorrento previously from our
develops you recall, is publicly As traded Sorrento and company cancer infectious may a biotech treatments that diseases. for
plus XXX%, repaid third [ph] the our During million at quarter loan exit $XX fees. was
in warrants positive exercising are remain million large rallied and identify had private also confident its term given that on company believe continue ahead proprietary near attractive to antibodies and will We news company $X.X that us, to we of the it prospects and attractive resources ample opportunities that its will We which been had months Sorrento, the positive COVID-XX. with treat increased have both at identified We value public several transactions. stock candidates OCSL quarter the on end, provide pharma collaboration to investments Oaktree’s with with and able are behind in companies. as we
detail. I to turn will over Mel our in Now financial the more call discuss to results
